In contrast, while GPX2 expression between pancreatic and colorectal carcinoma biopsies was very similar in our experiments (Figure 10C), UALCAN data indicate higher variability among pancreatic carcinoma patients (Supplementary Materials Figure S3C). This evidence concerns the gene GPX2 and colorectal carcinoma.